Tonix Pharmaceuticals Holding (TNXP) Asset Utilization Ratio (2023 - 2026)

Tonix Pharmaceuticals Holding's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.07 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 16.25% year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a 16.25% increase from a year earlier, with the FY2025 full-year figure at 0.06, down 6.36% from the prior year.
• Asset Utilization Ratio climbed to 0.07 in Q1 2026 per TNXP's latest filing, from 0.05 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.14 in Q3 2024 and bottomed at 0.05 in Q3 2025.
• The 4-year median for Asset Utilization Ratio is 0.08 (2024), against an average of 0.08.
• Across the five-year window, Asset Utilization Ratio climbed 28.44% in 2024 and tumbled 65.72% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.1 in 2023, then declined by 23.08% to 0.08 in 2024, then plunged by 36.77% to 0.05 in 2025, then jumped by 32.57% to 0.07 in 2026.
• Per Business Quant, the three latest TNXP Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.05 (Q4 2025), and 0.05 (Q3 2025).